Samuel Huber

University Medical Center Hamburg-Eppendorf

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

60%

Virology

30%

Immune Response

40%

Covid-19

30%

Inflammatory Biology

20%

Hepatocellular Carcinoma

20%

Immunogenetics

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Tr1 Cells Emerge and Suppress Effector Th17 Cells in Glomerulonephritis

Article Link

Year:

2023

Adhesion to laminin-1 and collagen IV induces the formation of Ca <sup>2+</sup> microdomains that sensitize mouse T cells for activation

Article Link

Year:

2023

A Critical Role of the IL-22–IL-22 Binding Protein Axis in Hepatocellular Carcinoma

Article Link

Year:

2022

Tissue Sampling and Homogenization with NIRL Enables Spatially Resolved Cell Layer Specific Proteomic Analysis of the Murine Intestine

Article Link

Year:

2022

CD4+ T-cell-derived IL-10 promotes CNS inflammation in mice by sustaining effector T cell survival

Article Link

Year:

2022

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Article Link

Year:

2022

Three Separate Spike Antigen Exposures by COVID-19 Vaccination or SARS-CoV-2 Infection Elicit Strong Humoral Immune Responses in Healthcare Workers

Article Link

Year:

2022

Disturbed lipid and amino acid metabolisms in COVID-19 patients.

Article Link

Year:

2022

Equal Efficacy and Safety Profile in Elderly Patients with Hepatocellular Carcinoma Receiving Palliative Treatment

Article Link

Year:

2022

High risk of complications and acute-on-chronic liver failure in cirrhosis patients with acute pancreatitis

Article Link

Year:

2022

High and Sustained Ex Vivo Frequency but Altered Phenotype of SARS-CoV-2-Specific CD4<sup>+</sup> T-Cells in an Anti-CD20-Treated Patient with Prolonged COVID-19

Article Link

Year:

2022

Collaborators18

Walter FRIES

Professore Ordinario di gastroenterologia

Università degli Studi di Palermo

ITALY

Jakob Seidelin

Københavns Universitet

DENMARK

Johann von Felden

University Medical Center Hamburg-Eppendorf

GERMANY

Gregory Thomas Charles Moore

MONASH UNIVERSITY

AUSTRALIA

Petra Clara Arck

Professor

University Medical Center Hamburg-Eppendorf

GERMANY

Björn-Philipp Diercks

University Medical Center Hamburg-Eppendorf

GERMANY

Julia K. Grass

University Medical Center Hamburg-Eppendorf

GERMANY

Jan Hahn

GERMANY

Johannes K. Knobloch

University Medical Center Hamburg-Eppendorf

GERMANY

Nicola Gagliani

University Medical Center Hamburg-Eppendorf

GERMANY

Peter Huebener

University Medical Center Hamburg-Eppendorf

GERMANY

Thomas Günther

Deputy Head of Virus Genomics, Senior Scientist

Leibniz-Institut für Experimentelle Virologie

GERMANY

Matthias Reeh

University Medical Center Hamburg-Eppendorf

GERMANY

Bu'Hussain Hayee

Professor in Gastroenterology

King’s College London

UNITED KINGDOM

Tarik Ghadban

University Medical Center Hamburg-Eppendorf

GERMANY

Coen Maas

Associate professor

University Medical Center Groningen

NETHERLANDS

Dorothee Schwinge

University Medical Center Hamburg-Eppendorf

GERMANY

Farhad Peerani

CANADA

How do I reach out?

Meet Kite AI